(SD2008-188) Anticancer Agents - Novel Spirohexenolides

Tech ID: 19781 / UC Case 2008-188-0

Technology Description

UC San Diego inventors have received a patent on a new chemical compound, isolated from a natural product that can inhibit progression through the cell cycle. The new structure's use as an anti-cancer agent is in the early stage of preclinical studies. This technology relates to novel spirohexenolides, biosynthetic methods for producing these spirohexenolides. and methods of treating cancer using the novel spirohexenolides.

This patented technology is available for commercial development within the United States (USA). Detailed description is available in the hyperlinked US Patent 8,653,283.

Related Materials

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 8,653,283 02/18/2014 2008-188
 

Other Information

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Inventors

  • Burkart, Michael D.

Other Information

Keywords

anti-mitotic, anti-fungal, anti-microbial, anti-cancer, tetrocarcins, kijanimicins, quartromicins, chlorothricins

Categorized As